Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines
- 31 January 2008
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 108 (1), 34-41
- https://doi.org/10.1016/j.ygyno.2007.08.096
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cellsBritish Journal of Cancer, 2006
- Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer CellsClinical Cancer Research, 2005
- Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene deliveryGynecologic Oncology, 2005
- AKT involvement in cisplatin chemoresistance of human uterine cancer cellsGynecologic Oncology, 2004
- Adenovirus-Mediated Transfer of siRNA against Survivin Induced Apoptosis and Attenuated Tumor Cell Growth in Vitro and in VivoMolecular Therapy, 2004
- Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substageGenes, Chromosomes and Cancer, 2004
- Role of Hec1 in Spindle Checkpoint Signaling and Kinetochore Recruitment of Mad1/Mad2Science, 2002
- RNA interferenceNature, 2002
- Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouseCancer Gene Therapy, 1999
- Protamine sulfate enhances lipid-mediated gene transferGene Therapy, 1997